Technology
Hexagon releases new targets at its Capital Markets Day 2026
Published
6 months agoon
By
Hexagon is the global leader in precision measurement, positioning and autonomous solutions with a serviceable addressable market of ~€38bn by 2030.Hexagon’s €3.7bn in revenue and ~17,000 employees are across three Business Areas – Manufacturing Intelligence, Infrastructure & Especial and Autonomous Solutions plus a Robotics Division currently in an investment phase.Recent portfolio actions, including the upcoming separation of Octave, the sale of the Design & Engineering business and the announced acquisition of Agate Technologies, have focused Hexagon on its strong core business in precision measurement & positioning technologies.Hexagon’s organic growth will be driven by strong end market potential and structural tailwinds, new product introductions and an operating model focused on accountability and closeness to customers.Hexagon launches new financial targets for the 2026 – 2030 period of average organic revenue growth of 4-6%, an EBITDA margin of 24-26%[1] and an EBITDA cash conversion of 90-100%. It also targets reducing Scope 1 & 2 emissions by 70% by 2030, from a 2022 baseline.
[1] EBITAC is defined as adjusted EBIT1 excluding capitalised and amortised R&D. See pages the appendix for further information
STOCKHOLM, April 30, 2026 /PRNewswire/ — Hexagon AB is hosting its Capital Markets Day today in London. At the event, President and CEO Anders Svensson, CFO Enrique Patrickson and the Presidents of Hexagon’s Business Areas will set out Hexagon’s ambitious growth strategy and its new 2026–2030 financial targets.
“Hexagon enters this new phase as a focused global leader in precision measurement and positioning, with a solutions portfolio essential to enabling industrial autonomy,” said Anders Svensson, President and CEO of Hexagon. “Our new targets reflect both the quality of our portfolio and the discipline of The Hexagon Way. With a strong leadership team and the financial flexibility to invest behind our growth priorities both organically and through synergistic acquisitions, we are well placed to deliver value creation for shareholders.”
“Today we are taking transparency to the next level — enhancing our disclosures, introducing EBITAC as our key profitability metric and providing clarity around our capital allocation priorities,” said Enrique Patrickson, CFO of Hexagon. “EBITAC is the right metric for Hexagon, a technology company with a significant R&D spend, funding market-leading product launches that drive our growth. With additional transparency comes additional accountability. We commit to drive capital allocation around R&D, M&A and Dividends with discipline and rigor.”
New sustainability targets
70% reduction in Scope 1 & 2 emissions by 2030 (from 2022 baseline)Net-zero by 2050
New 2026–2030 financial targets
Average annual organic revenue growth of 4-6%EBITAC margin in the range of 24-26%Annual cash conversion (of EBITAC) of 90-100%
A focused group focused on enabling industrial autonomy
Hexagon has undertaken significant portfolio changes, namely the upcoming spin-off of Octave and the sale of the Design & Engineering business. The resulting business is a focused global leader in precision measurement and positioning with proforma 2025 revenue of €3.7bn, EBITAC of €826m (22% EBITAC margin) and ~17,000 employees.
Hexagon is organised into three business areas – Manufacturing Intelligence, Infrastructure & Geospatial (formerly Geosystems) and Autonomous Solutions – alongside the Robotics Division, currently in an investment phase.
The overarching growth opportunity that underpins Hexagon’s long-term strategy is enabling customers to move towards true autonomy in their industrial operations.
President and CEO Anders Svensson will outline how Hexagon’s precision measurement and positioning technologies, digital twins and spatial intelligence capabilities are essential to enabling this true industrial autonomy. Hexagon holds market leadership positions across its serviceable addressable market, which is estimated to grow to ~€38bn by 2030.
Anders will also outline the key changes to Hexagon’s operating model. The Hexagon Way is an accountability-driven, decentralised model built around three strategic enablers: innovation and AI; portfolio management and M&A; and people & culture.
Central to this model is a clear accountability structure: the group’s three Business Areas are divided into 17 Divisions, each with full ownership of its financial performance and a defined strategic mandate covering three value creation priorities – Stability, Profitability and Growth.
The group-wide enablers allow Divisions to identify and execute on strategies targeted specifically to their markets and customers while drawing on the scale and resources of the broader Hexagon organisation. This balance of focused execution at the Division level and shared capability at the group level is designed to unlock each Division’s full potential and drive overall performance and shareholder value.
Hexagon’s new mid-term financial targets for 2026 to 2030 will be outlined by CFO Enrique Patrickson alongside a new financial framework including revised metric definitions designed to improve transparency, capital allocation and shareholder value creation.
The new 2026-30 through the cycle targets are:
Average annual organic revenue growth of 4–6% (CAGR 2026–2030)EBITAC margin in the range of 24–26%Annual cash conversion (of EBITAC) of 90–100%
In 2025, Hexagon achieved organic growth of 2.6%, an EBITAC margin of 22% and cash conversion (of EBITAC) of 109%.
Capital allocation
Hexagon’s capital allocation priorities are, in order: reinvestment in organic growth, value-accretive bolt-on M&A, a progressive dividend, and selective larger strategic moves where they enhance long-term shareholder value. The Group’s strong cash conversion and balance sheet provide the flexibility to pursue these priorities through the cycle.
Business Area presentations
Senior leadership from Hexagon’s Business Areas will provide additional context on strategy, markets and Business Area targets. The presenters will be:
Andreas Renulf, President, Manufacturing Intelligence Business AreaHenning Sandfort, President, Infrastructure & Geospatial Business AreaGordon Dale, President, Autonomous Solutions Business AreaArnaud Robert, President, Robotics Division
EBITAC – EBIT1 excluding capitalisation & amortisation of R&D
Hexagon is introducing EBITAC as its primary profitability measure. By immediately reflecting the full cost of R&D investments on the P&L, it will provide a tool to focus management firmly on the return on investment of R&D, go-to-market and capital investments and support performance management and capital allocation. The top end of the target EBITAC margin range (26%) was last achieved in 2021 and corresponds to the highest EBIT1 margin achieved by Hexagon in the last 5-years.
It is defined as adjusted EBIT1 excluding capitalised and amortised R&D.
Hexagon will continue to report EBIT1 (adjusted operating profit) for full transparency. A bridge between reported EBIT, EBIT1 and EBITAC and the EBITAC performance between 2024 and 2025 can be found in the appendix to this announcement.
Profitability metric bridge, 2025
Item
€M
Reported EBIT
575
Add: in year adjustments (impairments, restructuring, LTIP, PPA)
+372
EBIT1
947
Subtract: R&D capitalisation
-340
Add: R&D amortisation
+195
EBITAC
802
Subtract: in year robotics costs
+24
EBITAC (target definition)
826
Robotics – AEON, a potential global market leader in humanoid Robotics
Investment in Robotics to double from €24m in 2025 to €50m in 2026.Pilots with BMW, Schaeffler, Pilatus & Fill underway.Robotics is an exciting opportunity for significant value creation.
Due to its rapidly evolving structure Hexagon has decided to exclude Robotics from the 2026-30 financial targets and the calculation of EBITAC. This gives better visibility on the core group performance.
The financial performance of Robotics will be disclosed on a quarterly basis.
New sustainability targets
Hexagon is committed to operating responsibly for the good of the environment. It has set challenging new targets for emission reductions. Hexagon targets a 70% reduction in Scope 1 & 2 emissions by 2030 (from a 2022 baseline) and net-zero in Scope 1, 2 & 3 by 2050.
In 2025 Hexagon saw a 33% reduction in Scope 1 & 2 emissions from its 2022 baseline.
Joining instructions
The webcast will be streamed here: https://edge.media-server.com/mmc/p/d2han2qw/
FOR MORE INFORMATION, CONTACT:
Tom Hull, Head of Investor Relations, Hexagon AB, +44 7442 678 437, ir@hexagon.com
Anton Heikenström, Investor Relations Manager, Hexagon AB, +46 8 601 26 26, ir@hexagon.com
This is information that Hexagon AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:00 CET on 30 April 2026.
Appendix – Reconciling EBIT1 & EBITAC performance, 2025 quarterly
Metric
Q1 2025
Q2 2025
Q3 2025
Q4 2025
FY 2025
Revenue €m
961.5
1,010.5
976.0
1,053.1
4,001.2
EBIT1 €m
248.7
260.0
264.7
299.1
1,072.4
Subtract: capitalisation of R&D €m
-94.6
-94.7
-91.1
-84.1
-364.5
Add: amortisation of R&D €m
54.6
54.3
59.2
50.4
218.5
EBITAC €m
208.7
219.6
232.8
265.3
926.4
In year robotics cost €mEBIT
-4.7
-5.9
-5.6
-7.6
-23.7
EBITAC (excluding robotics costs)
213.4
225.5
238.3
272.9
950.1
EBIT1 margin %
25.9 %
25.7 %
27.1 %
28.4 %
26.8 %
EBITAC margin %
21.7 %
21.7 %
23.8 %
25.2 %
23.2 %
EBITAC margin % (excluding robotics costs)
22.2 %
22.3 %
24.4 %
25.9 %
23.7 %
Appendix – Reconciling EBIT1 & EBITAC performance, 2025 quarterly, excluding Design & Engineering
Metric
Q1 2025
Q2 2025
Q3 2025
Q4 2025
FY 2025
Revenue €m
888.2
939.4
907.1
980.3
3,715.0
EBIT1 €m
225.0
231.1
235.5
255.4
947.0
Subtract: capitalisation of R&D €m
-88.6
-88.0
-84.8
-78.3
-339.6
Add: amortisation of R&D €m
48.2
48.0
53.3
45.8
195.3
EBITAC €m
184.6
191.1
204.0
223.0
802.7
In year robotics cost €m
-4.7
-5.9
-5.6
-7.6
-23.7
EBITAC (excluding robotics costs)
189.3
196.9
209.6
230.5
826.4
EBIT1 margin %
25.3 %
24.6 %
26.0 %
26.1 %
25.5 %
EBITAC margin %
20.8 %
20.3 %
22.5 %
22.7 %
21.6 %
EBITAC margin % (excluding robotics costs)
21.3 %
21.0 %
23.1 %
23.5 %
22.2 %
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Main/387/4342580/4069574.pdf
Hexagon releases new targets at its Capital Markets Day 2026
View original content:https://www.prnewswire.com/news-releases/hexagon-releases-new-targets-at-its-capital-markets-day-2026-302758483.html
SOURCE Hexagon
You may like
From Nobel Prize Laureates and NASA Astronauts to Music Legends: STARMUS VIII Unites the World’s Greatest Minds in a Historic Celebration of Science, Music and Humanity
Tenerife & La Palma, Canary Islands, Spain | 17–22 October 2026
CANARY ISLANDS, Spain, Oct. 30, 2026 /PRNewswire/ — From the iconic sound of Sir Brian May’s legendary Red Special guitar and the extraordinary voices of Andrea Bocelli and Sarah Brightman to the groundbreaking discoveries of Nobel Prize-winning scientists, from NASA’s Artemis II astronauts preparing for humanity’s return to the Moon to historic tributes to Stephen Hawking and Jane Goodall, STARMUS VIII — The Search for Truth brought together an extraordinary constellation of scientific minds, legendary musicians, explorers and visionary thinkers for six unforgettable days in the Canary Islands.
Experience the full interactive Multichannel News Release here: https://www.multivu.com/starmus-foundation/9430551-en-starmus-viii-the-search-for-truth-festival-2026
Held across Tenerife and La Palma from 17 to 22 October 2026, the eighth edition of STARMUS transformed the islands into a global stage for scientific discovery, artistic excellence and some of the most important conversations shaping humanity’s future.
Founded by astrophysicist Dr. Garik Israelian and legendary Queen guitarist and astrophysicist Sir Brian May, STARMUS once again demonstrated its unique ability to bridge science, music and society, bringing complex scientific ideas to audiences through extraordinary encounters, performances and shared experiences.
This year’s festival marked two defining milestones: the 10th anniversary of the Stephen Hawking Medal for Science Communication and the inauguration of the Jane Goodall Earth Medal, establishing a powerful connection between humanity’s ambition to explore the universe and its responsibility to protect the planet we call home.
Media Contacts:
US: Dan DuPont, dupont0708@gmail.com, +1 202 380 7558
UK/EU: Nicole Ettinger, nicole@ettingerpr.com, +44 7515 394107
Spain: Carlos Esteban, cesteban@llys.global, +34 699 55 2854
View original content:https://www.prnewswire.com/news-releases/starmus-viii–the-search-for-truth-302924867.html
SOURCE Starmus Foundation
Technology
Membrane Chromatography Market worth $0.63 billion by 2031 – Exclusive Report by MarketsandMarkets™
Published
17 minutes agoon
October 30, 2026By
DELRAY BEACH, Fla., Oct. 30, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Membrane Chromatography Market is projected to reach USD 0.63 billion by 2031 from USD 0.37 billion in 2026, at a CAGR of 11.3% during the forecast period.
Browse 417 market data Tables and 51 Figures spread through 343 Pages and in-depth TOC on ‘Membrane Chromatography Market – Global Forecast to 2031’
Membrane Chromatography Market Size & Forecast:
Market Size Available for Years: 2026–20312026 Market Size: USD 0.37 billion2031 Projected Market Size: USD 0.63 billionCAGR (2026–2031): 11.3%
Membrane Chromatography Market Trends & Insights:
By region, North America accounted for the largest share of ~37.4% of the market in 2025.By product, the capsules, cassettes, and cartridges segment is projected to register the highest CAGR of 12.0% in the membrane chromatography market during the forecast period.By technique, the ion exchange membrane chromatography segment accounted for the largest share of 58.1% of the membrane chromatography market in 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151487196
The membrane chromatography market is expected to grow steadily as pharmaceutical and biotechnology companies increase investments in biologics, biosimilars, vaccines, cell & gene therapies, and other advanced therapeutic modalities. Growing production of monoclonal antibodies, recombinant proteins, viral vectors, plasmid DNA, and mRNA is increasing demand for membrane chromatography products, including capsules, cassettes & cartridges, membrane discs & sheets, syringe filters, filter plates, spin columns, and other consumables & accessories. Rising adoption of single-use downstream processing, flow-through purification, affinity capture, and high-throughput polishing is improving process flexibility, throughput, and manufacturing efficiency. Advances in membrane materials, surface functionalization, and high-capacity affinity membranes are further enhancing selectivity, binding capacity, and purification performance. These factors are supporting adoption across pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and academic & research institutes.
The market is increasingly shifting toward high-throughput, single-use, and application-specific membrane chromatography solutions that can support complex biologics and advanced therapeutic modalities. Although conventional resin-based chromatography remains widely adopted, demand is increasing for advanced membrane formats, improved ligand chemistries, higher binding capacities, and intensified flow-through and bind-elute purification approaches that can reduce processing time and improve downstream productivity. Suppliers are expanding product portfolios and developing specialized membrane chemistries to support monoclonal antibodies, viral vectors, plasmid DNA, mRNA, and other biomolecules with challenging purification requirements. At the same time, manufacturers are addressing challenges related to membrane fouling, scalability, selectivity, pressure handling, and process consistency through advanced membrane materials and optimized purification workflows. The growing outsourcing of bioprocess development and manufacturing further supports specialized membrane chromatography providers that can deliver scalable, high-throughput purification solutions with shorter turnaround times and consistent performance.
The flow-through membrane chromatography segment is expected to register the highest growth rate in the membrane chromatography market during the forecast period.
The membrane chromatography market is segmented by operation mode into flow-through membrane chromatography and bind-elute membrane chromatography. During the forecast period, flow-through membrane chromatography is projected to grow faster, supported by rising demand for high-throughput impurity removal, polishing, and process intensification in biopharmaceutical manufacturing. Flow-through processing enables rapid processing, lower pressure drops, reduced buffer consumption, and easier integration with single-use and continuous downstream workflows. However, bind-elute membrane chromatography remains an important operating mode because it supports selective capture and purification of target biomolecules across biologics and advanced therapy manufacturing applications.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=151487196
North America accounted for the largest regional share of the global membrane chromatography market in 2025.
The membrane chromatography market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America accounted for the largest share of the global market, driven by a well-established pharmaceutical and biotechnology industry, strong biopharmaceutical R&D activity, significant biologics manufacturing capacity, and widespread adoption of advanced downstream purification technologies. The region also benefits from major membrane chromatography product providers, pharmaceutical & biopharmaceutical companies, CROs & CDMOs, and research institutions. Continued development and commercialization of monoclonal antibodies, vaccines, viral vectors, and other advanced therapeutics, along with increasing adoption of single-use and high-throughput purification solutions, further support the region’s leading market position.
Key Players
Leading players in the Membrane Chromatography companies include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), i3 Membrane GmbH (Germany), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and MICROSOLV (US), among others.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=151487196
Investment & Funding Context
The membrane chromatography market is seeing increased investment as companies and research organizations focus on developing high-capacity membranes, scaling up manufacturing, advancing continuous downstream processing, and commercializing single-use purification technologies.
In June 2026, MembraneWorks, Inc. received USD 350,000 through the North Carolina Biotechnology Center’s Small Business Research Loan program to develop high-capacity nonwoven membrane chromatography devices for biopharmaceutical purification. The funding supports further development and commercialization of membrane-based downstream purification technologies.
In June 2025, a North Carolina State University research team received funding under the Gates Foundation-supported Grand Challenges initiative to develop a low-cost, all-membrane chromatography process to purify the antimalarial monoclonal antibody MAM01. The project focuses on single-use membranes, membrane-coupled ligands, scalable device configurations, integration into single-use cassettes, and development of an affordable, scalable biomanufacturing platform. These developments indicate continued funding toward membrane chromatography commercialization, high-capacity membrane devices, single-use purification, process intensification, and scalable biologics manufacturing.
Revenue Shift Context
The membrane chromatography market is gradually shifting from conventional resin-based chromatography and standalone filtration toward a broader mix of single-use membrane adsorbers, high-capacity affinity membranes, flow-through purification solutions, and application-specific consumables. Traditional products such as capsules, cassettes & cartridges, syringe filters, filter plates, spin columns, and membrane discs & sheets remain important revenue pools; however, customers increasingly seek integrated downstream solutions supporting monoclonal antibodies, viral vectors, plasmid DNA, mRNA, and other advanced therapeutic modalities.
Rising demand for single-use and high-throughput purification is further increasing consumption of specialized membrane formats and functionalized chemistries. At the same time, growing outsourcing by pharmaceutical & biopharmaceutical companies to CROs & CDMOs is expanding revenue opportunities for scalable purification platforms and related consumables. Over the forecast period, revenue growth is therefore expected to increasingly favor recurring membrane consumables, affinity membrane chromatography, advanced membrane materials, and integrated flow-through downstream processing workflows.
Mergers & Acquisitions
Mergers & acquisitions in the membrane chromatography market are increasingly focused on expanding downstream purification capabilities, strengthening membrane and filtration portfolios, and improving access to biopharmaceutical manufacturing customers. Buyers are prioritizing technologies that complement single-use processing, membrane-based separations, and integrated upstream-to-downstream workflows.
MEMBRANE CHROMATOGRAPHY MARKET: MERGERS & ACQUISITIONS, JANUARY 2025–SEPTEMBER 2026
Month & Year
Deal Type
Company
1
Company
2
Description
September 2025
Acquisition
Thermo Fisher Scientific Inc. (US)
Solventum Corporation – Purification & Filtration Business (US)
Thermo Fisher Scientific completed the acquisition of Solventum’s Purification & Filtration business for approximately USD 4.0 billion. The acquired business includes bioprocessing filtration and membrane technologies supporting upstream and downstream biopharmaceutical manufacturing. The portfolio includes Polisher ST Membrane Adsorber, a single-use anion exchange membrane chromatography solution for flow-through polishing and removal of host cell proteins, DNA, viruses, and other impurities. The acquisition strengthens Thermo Fisher’s membrane-based purification and broader downstream bioprocessing capabilities.
Company Revenue Share Details
The top four players collectively account for approximately 73–77% of the global membrane chromatography market, indicating a consolidated landscape. The market comprises a mix of diversified life science companies and specialized membrane chromatography product manufacturers. Leading players include Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), i3 Membrane GmbH (Germany), Agilent Technologies, Inc. (US), Donaldson Company, Inc. (US), GVS S.p.A. (Italy), Restek Corporation (US), Shimadzu Corporation (Japan), W. L. Gore & Associates, Inc. (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), MICROSOLV (US), among others. Their portfolio spans membrane adsorbers, capsules, cassettes & cartridges, syringe filters, filter plates, spin columns, membrane discs & sheets, and other consumables, along with ion exchange, affinity, and hydrophobic interaction membrane chromatography solutions. The coexistence of large, diversified companies and specialized membrane technology providers creates significant scope for continued competition and consolidation, particularly as companies expand single-use purification portfolios, high-capacity affinity membrane technologies, advanced membrane materials, and geographic reach.
Browse Adjacent Market: Biotechnology Market Research Reports &Consulting
See More Latest Biotechnology Reports:
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, NGS, PCR, Microscopy, Centrifuge, Liquid Handling), Application (Diagnostic, Research), End User (Pharma-Biopharma, Food, Hospital, Academia, CRO) – Global Forecast to 2031
Chromatography Columns Market by Column Type (Ion Exchange, Size Exclusion, Reverse and Normal Phases, HPLC, Affinity, Chiral), Capacity (1-100 ml, 100-1000 ml, >1 liter), End User (Pharma & Biotech, CRO, CDMO) – Global Forecast to 2031
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/membrane-chromatography-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/membrane-chromatography.asp
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/membrane-chromatography-market-worth-0-63-billion-by-2031—exclusive-report-by-marketsandmarkets-302924841.html
Technology
In HelloNation, Assisted Living Experts Rusty and Kelly Ackerman Explain Why Amenities Matter More Than Families Expect
Published
18 minutes agoon
October 30, 2026By
The article examines how amenities shape daily routines, independence, and social connection in senior living communities.
TRAVERSE CITY, Mich., Oct. 30, 2026 /PRNewswire/ — Why do senior living amenities have a greater impact on daily life than many families initially expect? HelloNation has released an article that explains how these features influence comfort, independence, and social connection in meaningful ways.
The article features insights from Assisted Living Experts Rusty and Kelly Ackerman of French Manor Assisted Living in Traverse City, Michigan, and highlights how senior living amenities play a central role in shaping everyday experiences within a community.
The HelloNation article explains that while families often focus on apartments and care services, senior living amenities are deeply connected to how residents spend their time. These amenities are not simply added features but part of the daily routine that supports both independence and engagement.
Dining options are one of the most impactful elements discussed. The article notes that meals are a daily experience that influence routine, health, and social connection. Asking about variety and flexibility helps families understand how dining options support both independence and comfort over time.
The article also explains that flexible dining options allow residents to make choices about when and what they eat. This ability to choose supports independence and reinforces a sense of control, which is especially important during transitions into a new living environment.
Activity spaces are another essential component of senior living amenities. The article describes how these spaces support hobbies, group events, and informal gatherings. Well-used activity spaces encourage residents to remain engaged and provide natural opportunities for social connection throughout the day.
In addition, activity spaces help foster spontaneous interaction. Residents may gather for conversation or shared interests, which strengthens community bonds. The article emphasizes that accessible and active spaces contribute directly to both engagement and independence.
Outdoor areas also play a significant role in daily life. The article explains that access to outdoor areas allows residents to enjoy fresh air, walk safely, and experience a change of environment. These outdoor areas help create a balanced routine and support emotional well-being.
The article further notes that time spent outdoors can improve mood and reduce stress. When outdoor areas are designed with safety and accessibility in mind, they support both independence and overall comfort.
Wellness programs are another key aspect of senior living amenities. The article describes how these programs provide structure through fitness and health-focused activities. Consistent wellness programs help residents maintain strength, confidence, and long-term well-being.
Wellness programs also encourage social connection by bringing residents together in shared activities. Participation in these programs helps build relationships while supporting physical health, reinforcing a sense of purpose within the community.
The article highlights that social connection is often shaped by how effectively senior living amenities are used. Dining options, activity spaces, outdoor areas, and wellness programs all create opportunities for interaction that help residents feel connected rather than isolated.
Senior living amenities also support independence in practical ways. Easy access to these features allows residents to make choices throughout the day, reinforcing confidence and autonomy over time.
Overall, the HelloNation article emphasizes that senior living amenities play a direct role in shaping comfort, independence, and social connection. Families are encouraged to look beyond appearance and ask how these amenities function on a daily basis to better understand the full living experience.
For families evaluating options, the article provides a clear perspective on how senior living amenities contribute to quality of life in ways that may not be immediately visible during a tour.
Why Amenities Matter More Than Families Expect features insights from Rusty and Kelly Ackerman, Assisted Living Experts of Traverse City, Michigan, in HelloNation.
About HelloNation
HelloNation is America’s Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.
View original content to download multimedia:https://www.prnewswire.com/news-releases/in-hellonation-assisted-living-experts-rusty-and-kelly-ackerman-explain-why-amenities-matter-more-than-families-expect-302925027.html
SOURCE HelloNation
STARMUS VIII — THE SEARCH FOR TRUTH
Membrane Chromatography Market worth $0.63 billion by 2031 – Exclusive Report by MarketsandMarkets™
In HelloNation, Assisted Living Experts Rusty and Kelly Ackerman Explain Why Amenities Matter More Than Families Expect
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Nullmax and Renesas Forge Strategic Partnership to Deliver Competitive ADAS Solutions for the Global Market
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Near Videos4 days agoNEAR is building a universal liquidity layer.
-
Technology5 days agoTin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf
-
Technology4 days agoTrueLoyal® Appoints Erica Thompson as Head of Loyalty
-
Technology5 days agoOASE+ and Elsevier Agree Next-Phase Read and Publish Agreement to Expand Open Access Publishing in Japan
-
Coin Market3 days agoBitcoin ETFs claw back $110M after $774M exit
-
Technology3 days agoSPS Releases New Report on Turning Workplace Data and AI into a Competitive Advantage
-
Technology5 days agoFFR to Hold Listing Ceremony and Investor Day on October 26; FFAI Announces Rescheduling of YT Jia’s Investor Weekly Report to October 26
-
Technology5 days agouSMART and PIVOT Fintech Introduce GlobalSave Portfolios Balanced Strategy on FollowSmart
